IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knight Therapeutics Inc (KHTRF)

CUSIP: 499053106 | NYSE | 4 institutional holders

Quarters

Q4 2021Q3 2020Q2 2020Q1 2020Q4 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2021

Bessemer Group Inc152,225
0.0% of portfolio›$637
StyleTurnoverLocationFiled
Bessemer Group Inc
152,225$6370.0%MomentumMediumWoodbridge, NJ2022-01-27